Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1

Conditions

Sarcoma 85Osteosarcoma 30Neuroectodermal Tumors, Primitive, Peripheral 16Fibrosarcoma 16Rhabdomyosarcoma 14Liposarcoma 14Hemangiosarcoma 13Neurofibrosarcoma 12Leiomyosarcoma 12Histiocytoma, Malignant Fibrous 12Sarcoma, Synovial 11Malignant mesenchymal tumor 9Sarcoma, Ewing 8Ovarian Neoplasms 8Hemangiopericytoma, Malignant 8Kidney Neoplasms 6Dendritic Cell Sarcoma, Interdigitating 6Wilms Tumor 5Sarcoma, Alveolar Soft Part 5Neoplasms 5Desmoplastic Small Round Cell Tumor 5Chondrosarcoma 5Carcinoma, Renal Cell 5Neuroblastoma 4Neoplasm Metastasis 4Medulloblastoma 4Lymphoma, Large B-Cell, Diffuse 4Dermatofibrosarcoma 4Chondrosarcoma, Extraskeletal Myxoid 4Central Nervous System Neoplasms 4

Interventions

seclidemstat 2Topotecan 2Cyclophosphamide 2selinexor 1pazopanib 1Zoledronic Acid 1Proton Therapy 1Ifosfamide 1Doxorubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myoepithelioma × Ifosfamide × Sarcoma × Clear all
NCT06239272 2026-05-19

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

St. Jude Children's Research Hospital

Phase 1/2 Recruiting
139 enrolled
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Glomus Tumor, Granuloma, Plasma Cell, Hemangiosarcoma, Liposarcoma, Myoepithelioma, Sarcoma, Osteosarcoma, Disorders of Sex Development, Granular Cell Tumor, Neoplasms, Adipose Tissue, Liposarcoma, Myxoid, Dermatofibrosarcoma, Sarcoma, Clear Cell, Smooth Muscle Tumor, Nerve Sheath Neoplasms, Neurofibrosarcoma, Hemangioendothelioma, Epithelioid, Vascular Neoplasms, Solitary Fibrous Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡